Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms

Annals of Neurology

Volumn 59, Issue 1, 2006, Pages 42-52

  Wu, Ying ^a   Buzzi, Andrea ^a   Frantseva, Marina ^a   Velazquez, Jose Perez L ^a,b   Cortez, Miguel ^a   Liu, Chunche ^a   Shen, Liqing ^a   Gibson, K Michael ^c   Snead III, O Carter ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; SUCCINATE SEMIALDEHYDE DEHYDROGENASE; TERT BUTYLBICYCLOPHOSPHOROTHIOATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; EPILEPTIC STATE; GRAND MAL SEIZURE; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; SEIZURE;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CONVULSANTS; HUMANS; MICE; MICE, KNOCKOUT; NEURONS; ORGANOPHOSPHORUS COMPOUNDS; PATCH-CLAMP TECHNIQUES; PROTEIN SUBUNITS; RADIOLIGAND ASSAY; RECEPTORS, GABA-A; STATUS EPILEPTICUS; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE; SULFUR RADIOISOTOPES;

EID: 29944446392     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20686     Document Type: Article

References (48)

1. Gibson KM, Hoffmann GF, Hodson AK, et al. 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 1998;29:14-22.
2. Pearl PL, Gibson KM, Acosta MT, et al. Clinical spectrum of succinic semialdehyde deficiency. Neurology 2003;60:1413-1417.
3. Dervent A, Gibson KM, Pearl PL, et al. Photosensitive absence epilepsy with myoclonias and heterozygosity for succinic semi-aldehyde dehydrogenase (SSADH) deficiency. Clin Neurophysiol 2004;1153:1417-1422.
4. Hogema BM, Gupta M, Senephansiri H, et al. Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat Genet 2001;29:212-216.
5. Gupta M, Hogema BM, Grompe M, et al. Murine succinate semialdehyde dehydrogenase deficiency. Ann Neurol 2003;54(suppl 6):S81-S90.
6. Cortez MA, Wu Y, Gibson KM, Snead OC. Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy. Pharmacol Biochem Behav 2004;79:547-553.
7. Snead OC, Hechler V, Vergnes M, Maitre M. Increased γ- hydroxybutyric acid receptors in thalamus of a genetic animal model of petit mal epilepsy. Epilepsy Res 1990;7:121-128.
8. 35S-t-butylbicyclophosphorothionate binding in rat brain: an autoradiographic study. J Neurosci 1990;10:603-612.
9. A-receptor complex in rat brain. Br J Pharmacol 1989;98:284-290.
10. Titulaer MN, Kamphuis W, Pool CW, et al. Kindling induces time-dependent and regional specific changes in the [3H]muscimol binding in the rat hippocampus: a quantitative autoradiographic study. Neuroscience 1994;59:817-826.
11. 3H]flunitrazepam binding throughout the rat brain: an autoradiographic study. J Pharmacol Exp Ther 1992;263:1401-1414.
12. Snead OC. Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. J Neurochem 2000;75:1986-1996.
13. 3H]gamma- hydroxybutyric acid binding sites in the thalamus and cortex. Neuroscience 1993;56:11-21.
14. Anderson RA, Ritzmann RF, Tabakoff B. Formation of gamma-hydroxybutyrate in brain. J Neurochem 1977;28:633-639.
15. Snead OC, Morley BJ. Ontogeny of γ-hydroxybutyric acid I: regional concentration in developing rat, monkey and human brain. Brain Res 1981;227:579-589.
16. Hamill OP, Marty A, Never E, et al. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
17. Snead OC, Depaulis A, Vergnes M, Marescaux C. Absence epilepsy: advances in experimental animal models. Adv Neurol 1999;79:253-278.
18. 35S]t butylbicyclophosphorothionate binding sites modulated by several allosteric ligands of gamma-aminobutyric acid type A receptors. Mol Pharmacol 1995;48:385-391.
19. A receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 2004;44:475-498.
20. Benke D, Fritschy JM, Trzeciak A, et al. Distribution, prevalence, and drug binding profile of gamma-aminobutyric acid type A receptor subtypes differing in the beta-subunit variant. J Biol Chem 1994;269:27100-27107.
21. Snead OC. γ-Hydroxybutyric and absence seizures activity. In: Tunnicliff G, Cash CD, eds. Gamma-hydroxybutyrate: molecular, functional and clinical aspects. London: Taylor & Francis, 2002:132-149.
22. Snead OC. Ontogeny of gamma-hydroxybutyric acid II: electroencephalographic effects. Brain Res 1984;317:89-96.
23. Treiman DM. GABAergrc mechanisms in epilepsy. Epilepsia 2001;42(suppl 3):8-12.
24. A receptors. Int Rev Neurobiol 1996;39:53-76.
25. A receptors. Epilepsy Res 2001;47:257-271.
26. Maloteaux JM, Octave JN, Gossuin A, et al. GABA induces down-regulation of the benzodiazepine-GABA receptor complex in the rat cultured neurons. Eur J Pharmacol 1987;144:173-183.
27. Baumgartner BJ, Harvey RJ, Darlison MG, Barnes EM. Developmental up-regulation and agonist-dependent down-regulation of GABAA receptor subunit mRNAs in chick cortical neurons. Mol Brain Res 1994;26:9-17.
28. Valeyev AY, Hackman JC, Holohean AM, et al. GABA-induced Cl- current in cultured embryonic human dorsal root ganglion neurons. J Neurophysiol 1999;82:1-9.
29. A receptor subunits in widespread brain regions in the freeze-lesion model of focal cortical malformations. J Neurosci 2000;20:5045-5053.
30. Czlonkowska AI, Krzascik P, Sienkiewicz-Jaros H, et al. Rapid down-regulation of GABA-A receptors after pretreatment of mice with progesterone. Pol J Pharmacol 2001;53:385-388.
31. Petrie J, Sapp DW, Tyndale RF, et al. Altered GABA(A) receptor subunit and splice variant expression in rats treated with chronic intermittent ethanol. Alcohol Clin Exp Res 2001;25:819-828.
32. Daglish MR, Nutt DJ. Brain imaging studies in human addicts. Eur Neuropsychopharmacol 2003;13:453-458.
33. A receptors in mediating the effects of alcohol in the central nervous system. J Psychiatr Neurosci 2003;28:263-274.
34. B receptors in the hippocampus. J Neurophysiol 2003;90:2690-2701.
35. Behrends JC. Modulation by bicuculline and penicillin of the block by t-butyl-bicyclo-phosphorothionate (TBPS) of GABA(A)-receptor mediated Cl(-)-current responses in rat striatal neurones. Br J Pharmacol 2000;129:402-408.
36. Fisher JL, Macdonald RL. Functional properties of recombinant GABA(A) receptors composed of single or multiple beta subunit subtypes. Neuropharmacology 1997;36:1601-1610.
37. Reynolds DS, Rosahl TW, Cirone J, et al. Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. J Neurosci 2003;23:8608-8617.
38. A receptor subunits contributing to the formation and affinity of the ter-burylbiciclophosphorothionate binding site. J Neurochem 2000;74:1310-1316.
39. Luddens H, Seeburg PHS, Korpi ER. Impact of beta and gamma variants on ligand binding properties of gamma-aminobutyric acid type A receptors. Mol Pharmacol 1994;45:810-814.
40. Korpi ER, Kuner T, Seeburg PH, Luddens H. A selective antagonist for the cerebellar granule cell-specific g-aminobutyric acid type A receptor. Mol Pharmacol 1995;47:283-289.
41. Luddens H, Korpi ER. GABA antagonists differentiate between recombinant GABAA/benzodiazepine receptor subtypes. J Neurosci 1995;15:6957-6962.
42. 35S]butylbicyclophosphoro-thionate binding in thalamic relay nuclei. J Pharmacol Exp Ther 1998;287:766-772.
43. A receptor binding and subunit mRNA level in rat brain by infusion of NOS inhibitor. Brain Res 2002;952:246-256.
44. DeLorey TM, Handforth A, Anagnostaras SG, et al. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 1998;18:8505-8514.
45. Fritschy JM, Brunig I. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol Ther 2003;98:299-323.
46. A receptor assembly and trafficking. Mol Neurobiol 2002;26:251-268.
47. Liu F, Wan Q, Pristupa Z, et al. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-amino butyric acid A receptors. Nature 2000;403:274-280.
48. Luscher B, Keller CA. Regulation of GABAA receptor trafficking, channel activity, and functional plasticity of inhibitory synapses. Pharmacol Ther 2004;102:195-221.